Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
New Perspectives in Pediatric Neurology-Multiple Sclerosis.
Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.
Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy.
White Matter Injury in Ischemic Stroke.
CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevance.
Identifying clues to molecular etiology of multiple sclerosis in South Indian patients.
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence.
Normal Diffusion-Weighted MRI During the Acute Stage of Central Pontine Myelinolysis.
Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Sharing data from MS clinical trials: Opportunities, challenges, and future directions.
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis.
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: utilization and valuation by patients.
Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
Understanding intellectual enrichment: how cognitive reserve impacts on hippocampal volume in multiple sclerosis.
The potential of LINGO-1 as a therapeutic target for essential tremor.
Expression of a single ICAMâ1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis.
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
Is there A Genetic Correlation between Multiple Sclerosis and Cerebral Aneurysms?
Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C.
Inhibin-a immunoreactivity in nervous system lesions.
Myelinating and demyelinating phenotype of Trembler-J mouse (a model of Charcot-Marie-Tooth human disease) analyzed by atomic force microscopy and confocal microscopy.

Pages